Compare Eli Lilly And Co (LLY) vs Rent the Runway Inc (RENT) Price & Performance

Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.

LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.

Rent the Runway (RENT) trades at $1.83, up 8.93% on the day, showing volatile earnings with recent quarterly beats but negative annual net income. The stock has a bullish technical signal despite mixed indicators, with valuation ratios appearing attractive (P/E 0.14, P/S 0.13). Revenue growth is improving, reaching $306.20M in 2025, with profitability metrics showing margin expansion from -104.19% in 2022 to -22.83% in 2025.

The outlook remains challenging with significant debt burden (debt-to-asset ratio 139.62%) and negative shareholder equity, though 2026 projections show potential profitability. Analyst consensus leans Hold (57.89%) with no Sell ratings, suggesting cautious optimism. Key risks include ongoing legal investigations and execution challenges in achieving sustained profitability.